Abstract
The purpose of this study was to determine the prevalence of BRCA1 mutations in Chinese breast cancer patients in Singapore. BRCA1 analysis was conducted in consecutive patients with breast cancer before the age of 40 years (76 women), or whose relatives had breast or ovarian cancer (16 women). Ten patients had both early onset breast cancer and affected relatives. Genomic DNA from peripheral mononuclear blood cells was studied by using the protein transcription–translation assay (exon 11) and single-strand conformational polymorphism, with subsequent DNA sequencing. All six disease-causing mutations occurred in women under 40 years (8.6%) with three occurring in patients under 35 years (three out of 22 patients, 13.6%). Mis-sense mutations of unknown significance were found in three patients. Two of the ten women with affected relatives under 40 years had BRCA1 mutations. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer is similar to that observed in Caucasian women. Most Chinese patients with affected relatives were not carriers of BRCA1 mutations. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Breast Information Core at www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic.
Chang-Claude J, Becher H, Eby N, Bastert G, Wahrendorf J and Hamann U (1997) Modifying effect of reproductive risk factors on age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123: 272–279
Cornelisse CJ, den Dunnen JT, Devilee P and van Ommen G-JB (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10: 208–212
Couch FJ and Weber BL Breast Information Core (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 8: 8–18
dos Santos Silva I and Swerdlow AJ (1995) Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 72: 485–492
Dunning AM, Chiano M, Smith NR, Dearden J, Gore M and Oakes S (1997) Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 6: 285–289
Ford D, Easton DF and Peto R (1995) Estimates of the gene frequency of BRCA1 and its contribution to cancer incidence. Am J Cancer Genetics 57: 1457–1462
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B and King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689
Hogervorst FBL, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JGN, Vaser HFA, Meijers-Heijboer H and Menko F (1996) Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet 5(9): 1289–1298
Inou R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T and Naga M (1995) Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res 15: 3521–3524
Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Iwase T, Kasumi F, Miki Y, Skolnick MH and Nakamura Y (1996) Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum Mutat 7: 334–339
Langston AA, Malone KE, Thompson JD, Daling JR and Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334: 137–142
Lee HP, Gourley L and Duffy SW (1991) Dietary effects on breast-cancer risk. Lancet 337: 1197–1200
Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV and Ostrander EA (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before 45 years with first-degree family history. JAMA 279: 922–929
Miki Y, Swensen J and Shattuck-Eidens D (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71
Narod SA, Goldgar D, Cannon-Albright L, Weber B, Molslehi R, Ives E, Lenoir G and Lynch H (1995) Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64: 394–398
Neuhasen SL, Mazoyer S, Friedman L, Stratton M, Offitt K, Calligo A, Tomlinson G and Cannon-Albright LL (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58: 271–280
Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J and Casey G (1995) Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet 4: 1989–1991
Sambrook J, Fritsch EF and Manitas T (1989). Isolation of High Molecular Weight DNA from Mammalian Cells. Cold Spring Harbor Laboratory Press: New York, pp. 14–23
Seow A, Duffy SW, McGee MA and Lee HP (1996) Breast cancer in Singapore: trends in incidence 1968–1992. Int J Epid 25: 40–45
Sharan SK, Wims M and Bradley A (1995) Murine BRCA1: sequence and significance for human mis-sense mutation. Hum Mol Genet 4: 2275–2278
Streuwing JP, Abeliovich D, Peretz T, Avishai N, Kaback M, Collins FS and Brody LC (1995) The carrier frequency of BRCA1 185delag is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11: 198–200
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sng, JH., Chang, J., Feroze, F. et al. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 82, 538–542 (2000). https://doi.org/10.1054/bjoc.1999.0960
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0960
Keywords
This article is cited by
-
Long-Term Treatment After Preoperative High-Dose Chemotherapy in a Lactating Breast Cancer Patient
Cell Biochemistry and Biophysics (2014)
-
BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer
Breast Cancer Research and Treatment (2009)
-
A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer
Breast Cancer Research and Treatment (2009)
-
Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer
Breast Cancer Research (2008)
-
Contribution of BRCA1 germline mutation in patients with sporadic breast cancer
International Seminars in Surgical Oncology (2008)